About the Oral Cavity Cancer Session
Oral cavity cancer, a subtype of head and neck cancer, poses significant challenges in diagnosis and treatment. Research in this field is pivotal in understanding its etiology, progression, and developing effective therapies. Studies focus on identifying risk factors such as tobacco and alcohol use, human papillomavirus (HPV) infection, and genetic predispositions. Advanced imaging techniques aid in early detection, improving prognosis. Additionally, molecular studies unravel the intricate mechanisms driving tumor growth and spread, paving the way for targeted therapies. Immunotherapies, including checkpoint inhibitors, show promise in bolstering the body's immune response against cancer cells. Multidisciplinary approaches integrating surgery, radiation, and chemotherapy continue to evolve, enhancing survival rates and quality of life for patients battling oral cavity cancer. Collaboration between clinicians, researchers, and pharmaceutical industries remains integral in advancing treatment paradigms for this challenging malignancy.
Topics Covered in Oral Cavity Cancer
Buccal Mucosa Cancer
Floor of Mouth Tumors
Depth of Invasion
Neck Dissection
Reconstructive Surgery
Adjuvant Chemoradiation
Related Scientific Sessions at CIOC 2027
Why Attend the Oral Cavity Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Oral Cavity Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Oral Cavity Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Oral Cavity Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Oral Cavity Cancer Conference 2027 — FAQs
What is the Oral Cavity Cancer track at CIOC 2027?
The Oral Cavity Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Oral Cavity Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Oral Cavity Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in Oral Cavity Cancer are all welcome — whether presenting or attending.
Can I present my research in the Oral Cavity Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Oral Cavity Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Oral Cavity Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.